SlideShare a Scribd company logo
1 of 10
Download to read offline
EGF
0 Human EGF is a 6045-Da protein with 53 amino acid
residues and three intramolecular disulfide bonds.
0 EGF acts by binding with
high affinity to EGFR on the
cell surface and stimulating
the intrinsic protein-tyrosine
kinase activity of the receptor.
0 Accelerate epidermal regeneration
of partial and full thickness skin wounds.
Background
But, the clinical use of rhEGF
in case of patients have generated some controversy in advantage.
Purposes
0 In this study,
0 Twelve patients had partial thickness wounds because of
burn and skin graft donor site were treated with rhEGF
0 We investigated the clinical effect of rhEGF on partial
thickness wounds of patients
Materials
0 Periods: Feb’08~Oct’08
0 Patients:
0 Patients that have second degree burn wounds (n=5)
0 Patients that have donor site wounds after skin graft (n=7)
0 Sex: all male
0 Age: 33.5
0 Exclusion: patients that have comorbidities,
such as DM or vascular diseases
Methods
0 Each wound was divided two areas (group A and B)
0 Marking 2 x 2 cm2 sized square shape
0 Treatment twice daily
0 Group A (experimental): foam dressing with rhEGF
0 Group B (control): foam dressing without rhEGF
Analysis
0 The extent of reepithelialized area was recorded by
percentage ratio
0 The statistical analysis was conducted about the
difference of the number of days between two area until
total wound was reepithelialized
Results
Patient Etiology of wound
Group A
(days)
Group B
(days)
Difference
(A-B, days)
1 Second-degree burn 10 13 -3
2 Skin graft donor site 11 11 0
3 Skin graft donor site 8 10 -2
4 Second-degree burn 11 9 2
5 Skin graft donor site 8 10 -2
6 Skin graft donor site 9 12 -3
7 Second-degree burn 12 11 1
8 Skin graft donor site 8 9 -1
9 Second-degree burn 10 12 -2
10 Skin graft donor site 9 10 -1
11 Second-degree burn 11 14 -3
12 Skin graft donor site 10 12 -2
Results
0 Healing time
0 Group A: 9.75 days (8-10 days)
0 Group B: 11.08 days (9-14 days)
0 Statistically significant difference between two groups (P < 0.05)
Conclusion
0 The topical application of rhEGF
0 Accelerated the re-epithelialization
0 Healing of partial-thickness wound clinically

More Related Content

Viewers also liked

Dynatrace Benchmarks For Travel
Dynatrace Benchmarks For TravelDynatrace Benchmarks For Travel
Dynatrace Benchmarks For Travel
Олег Дмитриев
 
Graebel_CitySynopsis_Chicago_US
Graebel_CitySynopsis_Chicago_USGraebel_CitySynopsis_Chicago_US
Graebel_CitySynopsis_Chicago_US
Pat Liberati
 

Viewers also liked (10)

Dynatrace Benchmarks For Travel
Dynatrace Benchmarks For TravelDynatrace Benchmarks For Travel
Dynatrace Benchmarks For Travel
 
Whey protein and its advantages
Whey protein and its advantagesWhey protein and its advantages
Whey protein and its advantages
 
Evaluation financiere de projet
Evaluation financiere de projetEvaluation financiere de projet
Evaluation financiere de projet
 
Graebel_CitySynopsis_Chicago_US
Graebel_CitySynopsis_Chicago_USGraebel_CitySynopsis_Chicago_US
Graebel_CitySynopsis_Chicago_US
 
Comprehensive & Participative Approach in Health Care Risk Management Program...
Comprehensive & Participative Approach in Health Care Risk Management Program...Comprehensive & Participative Approach in Health Care Risk Management Program...
Comprehensive & Participative Approach in Health Care Risk Management Program...
 
Management des délais
Management des délaisManagement des délais
Management des délais
 
Project Work Marketing Mix
Project Work Marketing Mix Project Work Marketing Mix
Project Work Marketing Mix
 
Haviksha Reddy's CV
Haviksha Reddy's CVHaviksha Reddy's CV
Haviksha Reddy's CV
 
EWMA 2013 - Ep515 - PROBLEMATIC WOUNDS UNDER COMPRESSION EXPERIENCES IN TREAT...
EWMA 2013 - Ep515 - PROBLEMATIC WOUNDS UNDER COMPRESSION EXPERIENCES IN TREAT...EWMA 2013 - Ep515 - PROBLEMATIC WOUNDS UNDER COMPRESSION EXPERIENCES IN TREAT...
EWMA 2013 - Ep515 - PROBLEMATIC WOUNDS UNDER COMPRESSION EXPERIENCES IN TREAT...
 
แหล่งท่องเที่ยวป่าเขาของไทย
แหล่งท่องเที่ยวป่าเขาของไทยแหล่งท่องเที่ยวป่าเขาของไทย
แหล่งท่องเที่ยวป่าเขาของไทย
 

Similar to EWMA 2013-Ep436-THE ACCELERATED EPITHELIALIZATION OF RECOMBINANT EPIDERMAL GROWTH FACTOR ON PARTIAL-THICKNESS SKIN WOUNDS

1_21_Epiona Clinical Study 62460 RN
1_21_Epiona Clinical Study 62460 RN1_21_Epiona Clinical Study 62460 RN
1_21_Epiona Clinical Study 62460 RN
Sally Dixon
 
Efficacy of Injectable Collagenase in the treatment of Dupuytren’s contractur...
Efficacy of Injectable Collagenase in the treatment of Dupuytren’s contractur...Efficacy of Injectable Collagenase in the treatment of Dupuytren’s contractur...
Efficacy of Injectable Collagenase in the treatment of Dupuytren’s contractur...
Dr. Mohamed El-Rouby دكتور محمد الروبي
 
Ewma 2014 ep399 results of a pilot, randomised, controlled clinical trial o...
Ewma 2014   ep399 results of a pilot, randomised, controlled clinical trial o...Ewma 2014   ep399 results of a pilot, randomised, controlled clinical trial o...
Ewma 2014 ep399 results of a pilot, randomised, controlled clinical trial o...
EWMA
 

Similar to EWMA 2013-Ep436-THE ACCELERATED EPITHELIALIZATION OF RECOMBINANT EPIDERMAL GROWTH FACTOR ON PARTIAL-THICKNESS SKIN WOUNDS (20)

Isx2006 clinical case presentation
Isx2006 clinical case presentationIsx2006 clinical case presentation
Isx2006 clinical case presentation
 
Content server (10)A randomized, controlled, double-blind prospective trial w...
Content server (10)A randomized, controlled, double-blind prospective trial w...Content server (10)A randomized, controlled, double-blind prospective trial w...
Content server (10)A randomized, controlled, double-blind prospective trial w...
 
Early excision and grafting for deep burns
Early excision and grafting for deep burnsEarly excision and grafting for deep burns
Early excision and grafting for deep burns
 
EWMA 2013 - Ep478 - Randomised controlled trial comparing a transforming meth...
EWMA 2013 - Ep478 - Randomised controlled trial comparing a transforming meth...EWMA 2013 - Ep478 - Randomised controlled trial comparing a transforming meth...
EWMA 2013 - Ep478 - Randomised controlled trial comparing a transforming meth...
 
EWMA 2013 - Ep478 - Randomised controlled trial comparing a transforming meth...
EWMA 2013 - Ep478 - Randomised controlled trial comparing a transforming meth...EWMA 2013 - Ep478 - Randomised controlled trial comparing a transforming meth...
EWMA 2013 - Ep478 - Randomised controlled trial comparing a transforming meth...
 
Light-Emitting Diode Irradiation Promotes Donor Site Wound Healing of the F...
Light-Emitting Diode Irradiation Promotes Donor Site Wound Healing of the F...Light-Emitting Diode Irradiation Promotes Donor Site Wound Healing of the F...
Light-Emitting Diode Irradiation Promotes Donor Site Wound Healing of the F...
 
Aloe Vera vs. SSD in the Treatment of Burns-Clinical Study
Aloe Vera vs. SSD in the Treatment of Burns-Clinical StudyAloe Vera vs. SSD in the Treatment of Burns-Clinical Study
Aloe Vera vs. SSD in the Treatment of Burns-Clinical Study
 
vancouver style of reference
vancouver style of referencevancouver style of reference
vancouver style of reference
 
Wound-Healing Effect of Aqueous Anthocephalus cadamba Leaf Extract [Autosaved...
Wound-Healing Effect of Aqueous Anthocephalus cadamba Leaf Extract [Autosaved...Wound-Healing Effect of Aqueous Anthocephalus cadamba Leaf Extract [Autosaved...
Wound-Healing Effect of Aqueous Anthocephalus cadamba Leaf Extract [Autosaved...
 
Early excision &skin grafting with M.Blue guide by dr. qutaiba aldoori
Early excision &skin grafting with M.Blue guide by dr. qutaiba aldooriEarly excision &skin grafting with M.Blue guide by dr. qutaiba aldoori
Early excision &skin grafting with M.Blue guide by dr. qutaiba aldoori
 
1_21_Epiona Clinical Study 62460 RN
1_21_Epiona Clinical Study 62460 RN1_21_Epiona Clinical Study 62460 RN
1_21_Epiona Clinical Study 62460 RN
 
EWMA 2013 - Ep486 - Efficacy trials on the use of a new dressing for the heal...
EWMA 2013 - Ep486 - Efficacy trials on the use of a new dressing for the heal...EWMA 2013 - Ep486 - Efficacy trials on the use of a new dressing for the heal...
EWMA 2013 - Ep486 - Efficacy trials on the use of a new dressing for the heal...
 
Efficacy of Injectable Collagenase in the treatment of Dupuytren’s contractur...
Efficacy of Injectable Collagenase in the treatment of Dupuytren’s contractur...Efficacy of Injectable Collagenase in the treatment of Dupuytren’s contractur...
Efficacy of Injectable Collagenase in the treatment of Dupuytren’s contractur...
 
Ewma 2014 ep399 results of a pilot, randomised, controlled clinical trial o...
Ewma 2014   ep399 results of a pilot, randomised, controlled clinical trial o...Ewma 2014   ep399 results of a pilot, randomised, controlled clinical trial o...
Ewma 2014 ep399 results of a pilot, randomised, controlled clinical trial o...
 
37th Publication- JFMPC- 6th Name.pdf
37th Publication- JFMPC- 6th Name.pdf37th Publication- JFMPC- 6th Name.pdf
37th Publication- JFMPC- 6th Name.pdf
 
155th publication jfmpc- 6th name
155th publication  jfmpc- 6th name155th publication  jfmpc- 6th name
155th publication jfmpc- 6th name
 
Journal club on Connective tissue graft associated or not with low laser ther...
Journal club on Connective tissue graft associated or not with low laser ther...Journal club on Connective tissue graft associated or not with low laser ther...
Journal club on Connective tissue graft associated or not with low laser ther...
 
Proposal of a tool for the assessment of the quality of Gaucher disease clini...
Proposal of a tool for the assessment of the quality of Gaucher disease clini...Proposal of a tool for the assessment of the quality of Gaucher disease clini...
Proposal of a tool for the assessment of the quality of Gaucher disease clini...
 
JC Presentation__Covid.pptx
JC Presentation__Covid.pptxJC Presentation__Covid.pptx
JC Presentation__Covid.pptx
 
RecoveryRx® Accelerated healing and better pain relief
RecoveryRx® Accelerated healing and better pain reliefRecoveryRx® Accelerated healing and better pain relief
RecoveryRx® Accelerated healing and better pain relief
 

More from EWMAConference

EWMA 2013 - Ep590 - HOLIDAY FEET: MANAGING A SUNBURNT FOOT USING THE RIGHT DR...
EWMA 2013 - Ep590 - HOLIDAY FEET: MANAGING A SUNBURNT FOOT USING THE RIGHT DR...EWMA 2013 - Ep590 - HOLIDAY FEET: MANAGING A SUNBURNT FOOT USING THE RIGHT DR...
EWMA 2013 - Ep590 - HOLIDAY FEET: MANAGING A SUNBURNT FOOT USING THE RIGHT DR...
EWMAConference
 

More from EWMAConference (20)

EWMA 2013 - Ep590 - HOLIDAY FEET: MANAGING A SUNBURNT FOOT USING THE RIGHT DR...
EWMA 2013 - Ep590 - HOLIDAY FEET: MANAGING A SUNBURNT FOOT USING THE RIGHT DR...EWMA 2013 - Ep590 - HOLIDAY FEET: MANAGING A SUNBURNT FOOT USING THE RIGHT DR...
EWMA 2013 - Ep590 - HOLIDAY FEET: MANAGING A SUNBURNT FOOT USING THE RIGHT DR...
 
EWMA 2013 - Ep589 - COST BENEFITS IN USING A MICROFIBER DEBRIDEMENT PAD IN TH...
EWMA 2013 - Ep589 - COST BENEFITS IN USING A MICROFIBER DEBRIDEMENT PAD IN TH...EWMA 2013 - Ep589 - COST BENEFITS IN USING A MICROFIBER DEBRIDEMENT PAD IN TH...
EWMA 2013 - Ep589 - COST BENEFITS IN USING A MICROFIBER DEBRIDEMENT PAD IN TH...
 
EWMA 2013 - Ep 587 - TREATMENT OF DIABETIC FOOT WITH COMBINATION OF TOPICAL N...
EWMA 2013 - Ep 587 - TREATMENT OF DIABETIC FOOT WITH COMBINATION OF TOPICAL N...EWMA 2013 - Ep 587 - TREATMENT OF DIABETIC FOOT WITH COMBINATION OF TOPICAL N...
EWMA 2013 - Ep 587 - TREATMENT OF DIABETIC FOOT WITH COMBINATION OF TOPICAL N...
 
EWMA 2013 - Ep580 - Treatment with negative pressure and drainage sheet for p...
EWMA 2013 - Ep580 - Treatment with negative pressure and drainage sheet for p...EWMA 2013 - Ep580 - Treatment with negative pressure and drainage sheet for p...
EWMA 2013 - Ep580 - Treatment with negative pressure and drainage sheet for p...
 
EWMA 2013 - EP579 - Cancer and epidermolysis bullosa - case report
EWMA 2013 - EP579 - Cancer and epidermolysis bullosa - case reportEWMA 2013 - EP579 - Cancer and epidermolysis bullosa - case report
EWMA 2013 - EP579 - Cancer and epidermolysis bullosa - case report
 
EWMA 2013 - Ep575 - A case of diabetic hand wound
EWMA 2013 - Ep575 - A case of diabetic hand woundEWMA 2013 - Ep575 - A case of diabetic hand wound
EWMA 2013 - Ep575 - A case of diabetic hand wound
 
EWMA 2013 - Ep574 - SOFT SILICONE AND LINOLEIC ACID TO TREAT CHONICAL WOUND I...
EWMA 2013 - Ep574 - SOFT SILICONE AND LINOLEIC ACID TO TREAT CHONICAL WOUND I...EWMA 2013 - Ep574 - SOFT SILICONE AND LINOLEIC ACID TO TREAT CHONICAL WOUND I...
EWMA 2013 - Ep574 - SOFT SILICONE AND LINOLEIC ACID TO TREAT CHONICAL WOUND I...
 
EWMA 2013 - Ep573 - INCIDENCE OF EPIDERMOLYIS BULLOSA AMONG COUPLES WITH CONS...
EWMA 2013 - Ep573 - INCIDENCE OF EPIDERMOLYIS BULLOSA AMONG COUPLES WITH CONS...EWMA 2013 - Ep573 - INCIDENCE OF EPIDERMOLYIS BULLOSA AMONG COUPLES WITH CONS...
EWMA 2013 - Ep573 - INCIDENCE OF EPIDERMOLYIS BULLOSA AMONG COUPLES WITH CONS...
 
EWMA 2013 - Ep570 - WHEN PERCEPTION IS NOT REALITY – LEG ULCER TREATMENT OF A...
EWMA 2013 - Ep570 - WHEN PERCEPTION IS NOT REALITY – LEG ULCER TREATMENT OF A...EWMA 2013 - Ep570 - WHEN PERCEPTION IS NOT REALITY – LEG ULCER TREATMENT OF A...
EWMA 2013 - Ep570 - WHEN PERCEPTION IS NOT REALITY – LEG ULCER TREATMENT OF A...
 
EWMA 2013 - Ep566 - SEQUENTIAL TREATMENT OF CHRONIC WOUNDS WITH HYDRO-DESLOUG...
EWMA 2013 - Ep566 - SEQUENTIAL TREATMENT OF CHRONIC WOUNDS WITH HYDRO-DESLOUG...EWMA 2013 - Ep566 - SEQUENTIAL TREATMENT OF CHRONIC WOUNDS WITH HYDRO-DESLOUG...
EWMA 2013 - Ep566 - SEQUENTIAL TREATMENT OF CHRONIC WOUNDS WITH HYDRO-DESLOUG...
 
EWMA 2013 - Ep565 - TREATMENT OF PRESSURE ULCERS IN TOES WITH A NEW HYDRO-DES...
EWMA 2013 - Ep565 - TREATMENT OF PRESSURE ULCERS IN TOES WITH A NEW HYDRO-DES...EWMA 2013 - Ep565 - TREATMENT OF PRESSURE ULCERS IN TOES WITH A NEW HYDRO-DES...
EWMA 2013 - Ep565 - TREATMENT OF PRESSURE ULCERS IN TOES WITH A NEW HYDRO-DES...
 
EWMA 2013 - Ep564 - DEVELOPING A TIME CONCEPT TREATMENT IN A POST-TRAUMATIC W...
EWMA 2013 - Ep564 - DEVELOPING A TIME CONCEPT TREATMENT IN A POST-TRAUMATIC W...EWMA 2013 - Ep564 - DEVELOPING A TIME CONCEPT TREATMENT IN A POST-TRAUMATIC W...
EWMA 2013 - Ep564 - DEVELOPING A TIME CONCEPT TREATMENT IN A POST-TRAUMATIC W...
 
EWMA 2013 - Ep563 - A new anti-biofilm dressing: in vivo investigation
EWMA 2013 - Ep563 - A new anti-biofilm dressing: in vivo investigationEWMA 2013 - Ep563 - A new anti-biofilm dressing: in vivo investigation
EWMA 2013 - Ep563 - A new anti-biofilm dressing: in vivo investigation
 
EWMA 2013 - Ep562 - MANAGEMENT OF AN ATYPICAL VASCULAR ULCER WITH TLC-NOSF DR...
EWMA 2013 - Ep562 - MANAGEMENT OF AN ATYPICAL VASCULAR ULCER WITH TLC-NOSF DR...EWMA 2013 - Ep562 - MANAGEMENT OF AN ATYPICAL VASCULAR ULCER WITH TLC-NOSF DR...
EWMA 2013 - Ep562 - MANAGEMENT OF AN ATYPICAL VASCULAR ULCER WITH TLC-NOSF DR...
 
EWMA 2013 - Ep559 - OUR EXPERIENCE IN THE HEALING OF TRAUMATIC WOUNDS WITH A ...
EWMA 2013 - Ep559 - OUR EXPERIENCE IN THE HEALING OF TRAUMATIC WOUNDS WITH A ...EWMA 2013 - Ep559 - OUR EXPERIENCE IN THE HEALING OF TRAUMATIC WOUNDS WITH A ...
EWMA 2013 - Ep559 - OUR EXPERIENCE IN THE HEALING OF TRAUMATIC WOUNDS WITH A ...
 
EWMA 2013 - Ep558 - USE OF A NEW HYDRO-DESLOUGHING ABSORBENT DRESSING* IN A N...
EWMA 2013 - Ep558 - USE OF A NEW HYDRO-DESLOUGHING ABSORBENT DRESSING* IN A N...EWMA 2013 - Ep558 - USE OF A NEW HYDRO-DESLOUGHING ABSORBENT DRESSING* IN A N...
EWMA 2013 - Ep558 - USE OF A NEW HYDRO-DESLOUGHING ABSORBENT DRESSING* IN A N...
 
EWMA 2013 - Ep556 - A CASE OF MULTIPLE CUTANEOUS ESCHARS FROM PYODERMA GANGRE...
EWMA 2013 - Ep556 - A CASE OF MULTIPLE CUTANEOUS ESCHARS FROM PYODERMA GANGRE...EWMA 2013 - Ep556 - A CASE OF MULTIPLE CUTANEOUS ESCHARS FROM PYODERMA GANGRE...
EWMA 2013 - Ep556 - A CASE OF MULTIPLE CUTANEOUS ESCHARS FROM PYODERMA GANGRE...
 
EWMA 2013 - Ep555 - Negatively Charged Microspheres- (NCM) Technology for The...
EWMA 2013 - Ep555 - Negatively Charged Microspheres- (NCM) Technology for The...EWMA 2013 - Ep555 - Negatively Charged Microspheres- (NCM) Technology for The...
EWMA 2013 - Ep555 - Negatively Charged Microspheres- (NCM) Technology for The...
 
EWMA 2013 - Ep552 - THE USE OF URINARY BLADDER MATRIX (ACELL) IN THE TREATMEN...
EWMA 2013 - Ep552 - THE USE OF URINARY BLADDER MATRIX (ACELL) IN THE TREATMEN...EWMA 2013 - Ep552 - THE USE OF URINARY BLADDER MATRIX (ACELL) IN THE TREATMEN...
EWMA 2013 - Ep552 - THE USE OF URINARY BLADDER MATRIX (ACELL) IN THE TREATMEN...
 
EWMA 2013 - Ep547 - European wound-registry (EWR) -characteristics and method...
EWMA 2013 - Ep547 - European wound-registry (EWR) -characteristics and method...EWMA 2013 - Ep547 - European wound-registry (EWR) -characteristics and method...
EWMA 2013 - Ep547 - European wound-registry (EWR) -characteristics and method...
 

Recently uploaded

Recently uploaded (20)

Automating Google Workspace (GWS) & more with Apps Script
Automating Google Workspace (GWS) & more with Apps ScriptAutomating Google Workspace (GWS) & more with Apps Script
Automating Google Workspace (GWS) & more with Apps Script
 
Boost PC performance: How more available memory can improve productivity
Boost PC performance: How more available memory can improve productivityBoost PC performance: How more available memory can improve productivity
Boost PC performance: How more available memory can improve productivity
 
Manulife - Insurer Innovation Award 2024
Manulife - Insurer Innovation Award 2024Manulife - Insurer Innovation Award 2024
Manulife - Insurer Innovation Award 2024
 
TrustArc Webinar - Stay Ahead of US State Data Privacy Law Developments
TrustArc Webinar - Stay Ahead of US State Data Privacy Law DevelopmentsTrustArc Webinar - Stay Ahead of US State Data Privacy Law Developments
TrustArc Webinar - Stay Ahead of US State Data Privacy Law Developments
 
Bajaj Allianz Life Insurance Company - Insurer Innovation Award 2024
Bajaj Allianz Life Insurance Company - Insurer Innovation Award 2024Bajaj Allianz Life Insurance Company - Insurer Innovation Award 2024
Bajaj Allianz Life Insurance Company - Insurer Innovation Award 2024
 
MINDCTI Revenue Release Quarter One 2024
MINDCTI Revenue Release Quarter One 2024MINDCTI Revenue Release Quarter One 2024
MINDCTI Revenue Release Quarter One 2024
 
🐬 The future of MySQL is Postgres 🐘
🐬  The future of MySQL is Postgres   🐘🐬  The future of MySQL is Postgres   🐘
🐬 The future of MySQL is Postgres 🐘
 
Bajaj Allianz Life Insurance Company - Insurer Innovation Award 2024
Bajaj Allianz Life Insurance Company - Insurer Innovation Award 2024Bajaj Allianz Life Insurance Company - Insurer Innovation Award 2024
Bajaj Allianz Life Insurance Company - Insurer Innovation Award 2024
 
Workshop - Best of Both Worlds_ Combine KG and Vector search for enhanced R...
Workshop - Best of Both Worlds_ Combine  KG and Vector search for  enhanced R...Workshop - Best of Both Worlds_ Combine  KG and Vector search for  enhanced R...
Workshop - Best of Both Worlds_ Combine KG and Vector search for enhanced R...
 
Boost Fertility New Invention Ups Success Rates.pdf
Boost Fertility New Invention Ups Success Rates.pdfBoost Fertility New Invention Ups Success Rates.pdf
Boost Fertility New Invention Ups Success Rates.pdf
 
Top 5 Benefits OF Using Muvi Live Paywall For Live Streams
Top 5 Benefits OF Using Muvi Live Paywall For Live StreamsTop 5 Benefits OF Using Muvi Live Paywall For Live Streams
Top 5 Benefits OF Using Muvi Live Paywall For Live Streams
 
Apidays New York 2024 - Scaling API-first by Ian Reasor and Radu Cotescu, Adobe
Apidays New York 2024 - Scaling API-first by Ian Reasor and Radu Cotescu, AdobeApidays New York 2024 - Scaling API-first by Ian Reasor and Radu Cotescu, Adobe
Apidays New York 2024 - Scaling API-first by Ian Reasor and Radu Cotescu, Adobe
 
Repurposing LNG terminals for Hydrogen Ammonia: Feasibility and Cost Saving
Repurposing LNG terminals for Hydrogen Ammonia: Feasibility and Cost SavingRepurposing LNG terminals for Hydrogen Ammonia: Feasibility and Cost Saving
Repurposing LNG terminals for Hydrogen Ammonia: Feasibility and Cost Saving
 
Real Time Object Detection Using Open CV
Real Time Object Detection Using Open CVReal Time Object Detection Using Open CV
Real Time Object Detection Using Open CV
 
AWS Community Day CPH - Three problems of Terraform
AWS Community Day CPH - Three problems of TerraformAWS Community Day CPH - Three problems of Terraform
AWS Community Day CPH - Three problems of Terraform
 
Strategies for Landing an Oracle DBA Job as a Fresher
Strategies for Landing an Oracle DBA Job as a FresherStrategies for Landing an Oracle DBA Job as a Fresher
Strategies for Landing an Oracle DBA Job as a Fresher
 
Strategies for Unlocking Knowledge Management in Microsoft 365 in the Copilot...
Strategies for Unlocking Knowledge Management in Microsoft 365 in the Copilot...Strategies for Unlocking Knowledge Management in Microsoft 365 in the Copilot...
Strategies for Unlocking Knowledge Management in Microsoft 365 in the Copilot...
 
Apidays Singapore 2024 - Building Digital Trust in a Digital Economy by Veron...
Apidays Singapore 2024 - Building Digital Trust in a Digital Economy by Veron...Apidays Singapore 2024 - Building Digital Trust in a Digital Economy by Veron...
Apidays Singapore 2024 - Building Digital Trust in a Digital Economy by Veron...
 
How to Troubleshoot Apps for the Modern Connected Worker
How to Troubleshoot Apps for the Modern Connected WorkerHow to Troubleshoot Apps for the Modern Connected Worker
How to Troubleshoot Apps for the Modern Connected Worker
 
Apidays New York 2024 - The value of a flexible API Management solution for O...
Apidays New York 2024 - The value of a flexible API Management solution for O...Apidays New York 2024 - The value of a flexible API Management solution for O...
Apidays New York 2024 - The value of a flexible API Management solution for O...
 

EWMA 2013-Ep436-THE ACCELERATED EPITHELIALIZATION OF RECOMBINANT EPIDERMAL GROWTH FACTOR ON PARTIAL-THICKNESS SKIN WOUNDS

  • 1.
  • 2. EGF 0 Human EGF is a 6045-Da protein with 53 amino acid residues and three intramolecular disulfide bonds. 0 EGF acts by binding with high affinity to EGFR on the cell surface and stimulating the intrinsic protein-tyrosine kinase activity of the receptor. 0 Accelerate epidermal regeneration of partial and full thickness skin wounds.
  • 3. Background But, the clinical use of rhEGF in case of patients have generated some controversy in advantage.
  • 4. Purposes 0 In this study, 0 Twelve patients had partial thickness wounds because of burn and skin graft donor site were treated with rhEGF 0 We investigated the clinical effect of rhEGF on partial thickness wounds of patients
  • 5. Materials 0 Periods: Feb’08~Oct’08 0 Patients: 0 Patients that have second degree burn wounds (n=5) 0 Patients that have donor site wounds after skin graft (n=7) 0 Sex: all male 0 Age: 33.5 0 Exclusion: patients that have comorbidities, such as DM or vascular diseases
  • 6. Methods 0 Each wound was divided two areas (group A and B) 0 Marking 2 x 2 cm2 sized square shape 0 Treatment twice daily 0 Group A (experimental): foam dressing with rhEGF 0 Group B (control): foam dressing without rhEGF
  • 7. Analysis 0 The extent of reepithelialized area was recorded by percentage ratio 0 The statistical analysis was conducted about the difference of the number of days between two area until total wound was reepithelialized
  • 8. Results Patient Etiology of wound Group A (days) Group B (days) Difference (A-B, days) 1 Second-degree burn 10 13 -3 2 Skin graft donor site 11 11 0 3 Skin graft donor site 8 10 -2 4 Second-degree burn 11 9 2 5 Skin graft donor site 8 10 -2 6 Skin graft donor site 9 12 -3 7 Second-degree burn 12 11 1 8 Skin graft donor site 8 9 -1 9 Second-degree burn 10 12 -2 10 Skin graft donor site 9 10 -1 11 Second-degree burn 11 14 -3 12 Skin graft donor site 10 12 -2
  • 9. Results 0 Healing time 0 Group A: 9.75 days (8-10 days) 0 Group B: 11.08 days (9-14 days) 0 Statistically significant difference between two groups (P < 0.05)
  • 10. Conclusion 0 The topical application of rhEGF 0 Accelerated the re-epithelialization 0 Healing of partial-thickness wound clinically